Recombinant Human Inositol Monophosphatase 2 is produced by our E.coli expression system and the target gene encoding Met1-Lys288 is expressed with a 6His tag at the N-terminus.

Recombinant Human Inositol Monophosphatase 2/IMPase 2 (N-6His)

Name: Recombinant Human Inositol Monophosphatase 2/IMPase 2 (N-6His)
SKU: CE24-10ug

SKU: CE24-10ug

$158.00

Quantity

[{"key":"CE24-500ug","value":"Backorder"},{"key":"CE24-50ug","value":"Backorder"},{"key":"CE24-10ug","value":"Backorder"}]

FAQ

Contact Us

Phone: 800-943-6396 ext#1

Email: orders@bonopusbio.com

Distributors

Have Other Questions?

Shipping Information

$48 Standard Overnight flat rate for products shipped in room temperature within the United States.

Additional $27 Ice Packs shipment fee is required for liquid proteins.

Please contact us to order for international shipments.

Certificate of Analysis

Datasheet not available? Submit a request here

Endotoxin

Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.

Accession Number

O14732

Species

Human

Expression System

E.coli

Target Sequence

Met1-Lys288

N-His

Formulation

Supplied as a 0.2 um filtered solution of 20mM Tris-HCl, 2mM DTT, pH 8.0.

Packaging

Dry Ice/ice packs

Background

Inositol monophosphatase 2, also known as Inositol-1(or 4)-monophosphatase 2, Myo-inositol monophosphatase A2 and IMPA2, is an enzyme which belongs to the inositol monophosphatase family. IMPA2 catalyzes the dephosphoylration of inositol monophosphate with cofactor Magnesium and Inhibited by high Li+ and restricted Mg2+ concentrations. IMPA2 plays an important role in phosphatidylinositol signaling. IMPA2 can use the myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. IMPA2 is a pharmacological target for lithium Li(+) action in brain, it is considered to have a role in schizophrenia and bipolar disorder.